Quick Answer
Tectonic Therapeutic, Inc. reported Total Assets of $261.04 million for the year ending 2025.
- Tectonic Therapeutic, Inc. showed an increase of +70.7% in Total Assets from 2024 to 2025.
- This data is from Tectonic Therapeutic, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2018: $158.73 million | Q3 2018: $143.27 million | Q1 2019: $117.37 million | Q2 2019: $101.99 million | Q3 2019: $217.21 million | Q1 2020: $269.73 million | Q2 2020: $255.57 million | Q3 2020: $233.26 million | Q1 2021: $245.91 million | Q2 2021: $238.10 million | Q3 2021: $216.45 million | Q1 2022: $175.34 million | Q2 2022: $146.24 million | Q3 2022: $129.50 million | Q1 2023: $83.01 million | Q2 2023: $133.84 million | Q3 2023: $110.52 million | Q1 2024: $92.35 million | Q2 2024: $193.91 million | Q3 2024: $168.72 million | Q1 2025: $314.83 million | Q2 2025: $295.31 million | Q3 2025: $277.00 million.
- Over the full 9 years of available data (2017 to 2025), Tectonic Therapeutic, Inc.'s Total Assets has grown by 3,617.4%.
- Historical annual values: Fiscal year 2025: $261.04 million | Fiscal year 2024: $152.91 million | Fiscal year 2023: $39.40 million | Fiscal year 2022: $103.95 million | Fiscal year 2021: $203.84 million | Fiscal year 2020: $271.23 million | Fiscal year 2019: $200.51 million | Fiscal year 2018: $133.48 million | Fiscal year 2017: $7.02 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: